CDER’s Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 26, 2023
July 26, 2023
8610d370-6b09-40a5-9d6b-24ac4df3f732
Related Documents
Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products
Guidance DocumentMay 1, 2023Center for Drug Evaluation and Research
Questions and Answers on Quality Related Controlled Correspondence Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 20, 2021Center for Drug Evaluation and Research
Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals
Guidance DocumentJune 5, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox